Filtered By:
Infectious Disease: Epidemics
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 24639 results found since Jan 2013.
The perfect storm: temporal analysis of air during the world's most deadly epidemic thunderstorm asthma (ETSA) event in Melbourne
CONCLUSION: The findings presented in this article highlight the importance of including ruptured pollen and time-resolved analysis to forecast ETSA events and thus save lives.PMID:37646293 | PMC:PMC10469229 | DOI:10.1177/17534666231186726
Source: Respiratory Care - August 30, 2023 Category: Respiratory Medicine Authors: Dwan Price Kira M Hughes Dulashi Withanage Dona Philip E Taylor David A V Morton Svetlana Stevanovic Francis Thien Jason Choi Paul Torre Cenk Suphioglu Source Type: research
Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders
CONCLUSIONS: SARS-CoV-2 can lead to neurological complications, such as cerebrovascular manifestations, motor movement complications, and cognitive decline. COVID-19 infection can result in cerebrovascular symptoms and diseases, such as strokes and thrombosis. The virus can affect the neural system, disrupt cognitive function and cause neurological disorders. To combat the epidemic, it is crucial to repurpose drugs currently in use quickly and develop novel therapeutics.PMID:37649125 | PMC:PMC10469568 | DOI:10.1186/s40001-023-01293-2
Source: Cell Research - August 30, 2023 Category: Cytology Authors: Kritika Tyagi Prachi Rai Anuj Gautam Harjeet Kaur Sumeet Kapoor Ashish Suttee Pradeep Kumar Jaiswal Akanksha Sharma Gurpal Singh Ravi Pratap Barnwal Source Type: research
Research Progress in Nanopharmaceuticals with Different Delivery Routes in the Antivirus Field
Curr Pharm Des. 2023 Aug 30. doi: 10.2174/1381612829666230830105817. Online ahead of print.ABSTRACTHuman health is significantly threatened by infectious diseases caused by viral infection. Over the years, there have been numerous virus epidemics worldwide, causing millions of deaths. Traditional antiviral medications have many problems, including poor solubility and antiviral resistance. Additionally, because different drug delivery methods have different biological barriers to overcome, the drug's bioavailability will be significantly affected. Therefore, it is essential that researchers create more effective antiviral d...
Source: Current Pharmaceutical Design - August 30, 2023 Category: Drugs & Pharmacology Authors: Yenong Shi Dongqiong He Xianwei Zhang Mingqing Yuan Xu Liu Source Type: research
The perfect storm: temporal analysis of air during the world's most deadly epidemic thunderstorm asthma (ETSA) event in Melbourne
CONCLUSION: The findings presented in this article highlight the importance of including ruptured pollen and time-resolved analysis to forecast ETSA events and thus save lives.PMID:37646293 | DOI:10.1177/17534666231186726
Source: Respiratory Care - August 30, 2023 Category: Respiratory Medicine Authors: Dwan Price Kira M Hughes Dulashi Withanage Dona Philip E Taylor David A V Morton Svetlana Stevanovic Francis Thien Jason Choi Paul Torre Cenk Suphioglu Source Type: research
Research Progress in Nanopharmaceuticals with Different Delivery Routes in the Antivirus Field
Curr Pharm Des. 2023 Aug 30. doi: 10.2174/1381612829666230830105817. Online ahead of print.ABSTRACTHuman health is significantly threatened by infectious diseases caused by viral infection. Over the years, there have been numerous virus epidemics worldwide, causing millions of deaths. Traditional antiviral medications have many problems, including poor solubility and antiviral resistance. Additionally, because different drug delivery methods have different biological barriers to overcome, the drug's bioavailability will be significantly affected. Therefore, it is essential that researchers create more effective antiviral d...
Source: Current Pharmaceutical Design - August 30, 2023 Category: Drugs & Pharmacology Authors: Yenong Shi Dongqiong He Xianwei Zhang Mingqing Yuan Xu Liu Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
China's carbon emissions peaking pathway in the post-COVID-19 era
Environ Sci Pollut Res Int. 2023 Aug 29. doi: 10.1007/s11356-023-29400-0. Online ahead of print.ABSTRACTSeveral countries have weakened the carbon emission objectives to immediately revive the economy in the post-COVID-19 era. Therefore, it is a challenge worth addressing to readjust the economic development and carbon emissions after the COVID-19 pandemic. From the perspective of China's carbon emissions, this study shapes a multi-objective dynamic optimization model based on the material capital input and R&D support aspects. The proposed model imitates China's economic development, energy consumption, and carbon dio...
Source: Environmental Science and Pollution Research International - August 29, 2023 Category: Environmental Health Authors: Da Liu Shengyan Wang Xudong Zhao Jiaying Wang Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
< em > Clostridioides difficile < /em > resistance to antibiotics, including post-COVID-19 data
Expert Rev Clin Pharmacol. 2023 Aug 29:1-14. doi: 10.1080/17512433.2023.2252331. Online ahead of print.ABSTRACTINTRODUCTION: Updating data on Clostridioides difficile antibiotic resistance is important for treatment improvement of C. difficile infections (CDIs).AREAS COVERED: Results from 20 countries were included. The mean resistance to 2 mg/l vancomycin, 2 mg/l metronidazole, 4 mg/l moxifloxacin, and 4 mg/l clindamycin was 4.7% (0 to ≥ 26% in two studies), 2.6% (0 to ≥ 40% in 3 studies), 34.9% (6.6->80%), and 61.0% (30->90%), respectively. Resistance to erythromycin (>60-88%), rifampin (>23-55.0%), imipe...
Source: Pharmacological Reviews - August 29, 2023 Category: Drugs & Pharmacology Authors: Lyudmila Boyanova Georgi Dimitrov Raina Gergova Petyo Hadzhiyski Rumyana Markovska Source Type: research
Identification of the Near Full-length Genome of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant with a Complex Genomic Structure Isolated in Hebei Province, China
CONCLUSION: The increase in CRF01_AE/CRF07_BC recombinant viruses suggests that HIV-1 has a high genetic mutation rate in Hebei, China. This highlights the need for close monitoring of HIV-1 molecular epidemiologic changes to provide accurate, up-to-date information for effective disease control.PMID:37642005 | DOI:10.2174/1570162X21666230828122711
Source: Current HIV Research - August 29, 2023 Category: Infectious Diseases Authors: Weina An Jianru Jia Haoxi Shi Miaomiao Su Juan Meng Weiguang Fan Source Type: research
< em > Clostridioides difficile < /em > resistance to antibiotics, including post-COVID-19 data
Expert Rev Clin Pharmacol. 2023 Aug 29:1-14. doi: 10.1080/17512433.2023.2252331. Online ahead of print.ABSTRACTINTRODUCTION: Updating data on Clostridioides difficile antibiotic resistance is important for treatment improvement of C. difficile infections (CDIs).AREAS COVERED: Results from 20 countries were included. The mean resistance to 2 mg/l vancomycin, 2 mg/l metronidazole, 4 mg/l moxifloxacin, and 4 mg/l clindamycin was 4.7% (0 to ≥ 26% in two studies), 2.6% (0 to ≥ 40% in 3 studies), 34.9% (6.6->80%), and 61.0% (30->90%), respectively. Resistance to erythromycin (>60-88%), rifampin (>23-55.0%), imipe...
Source: Pharmacological Reviews - August 29, 2023 Category: Drugs & Pharmacology Authors: Lyudmila Boyanova Georgi Dimitrov Raina Gergova Petyo Hadzhiyski Rumyana Markovska Source Type: research
